Up tókànItọsọna atẹle
AI ni Iṣakoso Yiyika Owo ti Ilera
Awọn ile-iṣẹ
Awọn ile-iṣẹ Itọsọna
AI ni ilera le ṣe atilẹyin aworan, iwe-aṣẹ, triage, iwadii, ati iṣẹ iṣakoso.
Gbọ si itọsọna yiiAI-ṣe afihan · ~2 min
The right evaluation depends on the intended use, patient population, clinical workflow, and consequences of error. A model that performs well on one dataset is not automatically ready to guide care.
Define the clinical or operational purpose before choosing a model. A system that prioritizes records, suggests a finding, and makes a treatment recommendation have different risk profiles and evidence requirements. Identify who reviews the output, what information they see, and what happens when the system is unavailable or uncertain. Use representative data and preserve the distinction between development, validation, and real-world evaluation. Check subgroup performance, missing data, device differences, and changes in clinical practice. A retrospective result can support investigation while still falling short of evidence for prospective use. Document the model, data, version, and context of use. FDA’s AI-enabled device list emphasizes the relationship between a device’s intended use, technology, and applicable review. Regulatory status is specific to the authorized device and use; it is not a general endorsement of every model or workflow. Protect health information across inputs, logs, derived features, and outputs. Keep a qualified human decision-maker responsible for consequential care and provide a route to investigate and correct errors.
04Apẹẹrẹ ṣiṣẹ
Imagine a model ranking 100 emergency records for review and a second system suggesting a diagnosis.
Measure whether the first ranking helps clinicians find urgent cases; do not treat that result as evidence for the second system’s diagnosis.
Test missed cases, review time, and escalation procedures before using either output in practice.
Ohun ti o fihan
This constructed example shows why healthcare evidence must match the precise intended use.
Evaluate an imaging aid on cases from the intended scanners and patient population.
Show a clinician the supporting image region and uncertainty before review.
Ìwé ìròyìn ọfẹ
Ìtàn AI mẹta tó jẹ́rìí ní gbogbo owurọ́ ọjọ́ iṣẹ́, kọ́wé ní Gẹ̀ẹ́sì tó rọrùn. Ọfẹ́ fún gbogbo àkókò, kò sí ìpolówó.
Ìmeèlì kan ní gbogbo ọjọ́ iṣẹ́. Yọkúrò ní ìkànìyàn ní ìkànìyàn kan. A kò ta tàbí pín àdírẹ́sì rẹ.
Ṣe idanwo fun ara rẹ
Ìdáhùn lẹ́sẹ̀kẹsẹ̀ lórí gbogbo ìdáhùn, àti iwe-ẹ̀rí tó lè pin pẹ̀lú ID tó lè jẹ́rìí lẹ́yìn tí o bá kọ́ ẹ̀kọ́.
Ṣe àtìlẹ́yìn ẹ̀kọ́ AI ọfẹ́. AI Understanding jẹ́ àjọ àìní èrè 501(c)(3) — kò sí ìpolówó, kò sí àkúnya owó, ní gbogbo àkókò. Ṣe ẹbun kan
No. The list concerns devices authorized for particular uses and does not certify unrelated models or workflows.
Tesiwaju kikọ
Awọn itọsọna diẹ sii ti a yan fun koko yii
Up tókànItọsọna atẹle
AI ni Iṣakoso Yiyika Owo ti Ilera
Awọn ile-iṣẹ